Guilandina minax
Guilandina minax · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Guilandina minax is a botanical species that has garnered significant scientific interest due to its diverse pharmacological potential. Research focuses specifically on the seeds of this plant, particularly when processed as an ethyl acetate extract. Chemical analysis has identified key bioactive compounds within these seeds, including Caesalmin C, D-, F-, and Minaxin C. These constituents have demonstrated promising antimalarial and antiviral activities in various studies. Furthermore, investigations are exploring the therapeutic relevance of these extracts in managing conditions such as pituitary adenoma.
- Synonyms
- Caesalpinia Minax · Caesalpinia Minax Var. Burmanica · 1 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Seed
Classification
Common Names
Guilandina minax is a distinctive plant known by several different common names depending on the regional language. In certain contexts, it is referred to as 喙荚鹰叶刺, highlighting its unique physical characteristics. It is also widely recognized by the names 喙莢雲實 and 南蛇簕, which are frequently used in botanical discussions. Furthermore, the species is identified as 蓮實藤 in various traditional classifications. These diverse names reflect the plant's multifaceted identity across different cultural and linguistic landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Guilandina minax is a botanical subject characterized by a complex web of taxonomic synonyms. Within scientific literature, this species is frequently identified by the name Caesalpinia minax. Further classification nuances include the recognized variety known as Caesalpinia minax var. burmanica. Additionally, researchers may encounter the plant referred to under the synonym Caesalpinia morsei. Understanding these overlapping names is essential for ensuring accuracy in botanical studies and plant identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Guilandina minax belongs to the vast kingdom Plantae, representing a unique branch of the natural world. Within this kingdom, it is classified under the class Equisetopsida and the order Fabales. This specific botanical lineage places the species firmly within the diverse family Fabaceae. It is further identified by its distinct genus, which is also known as Guilandina. Through these scientific relationships, we gain a clearer understanding of the plant's evolutionary position.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Guilandina |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Guilandina minax is a versatile species with a broad geographical footprint across the Asian continent. Its presence spans the temperate regions of China, specifically throughout the South-Central and Southeast territories. The plant also thrives in Eastern Asia, with documented occurrences in Taiwan. Moving into tropical climates, it can be found within the Indian Subcontinent, specifically in Assam. Finally, its range extends into the East Himalaya, demonstrating a remarkable ability to inhabit diverse ecological niches.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Guilandina minax is characterized by an obligatory climbing habit, meaning it relies entirely on surrounding structures for support to reach the sunlight it needs to thrive.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Guilandina minax, also known as Caesalpinia minax, serves as a rich natural source for potent bioactive compounds. Research into the seeds of this plant has led to the isolation of unique diterpene alkaloids that exhibit significant antimalarial activity. Specifically, compounds such as caesalminines A and B have demonstrated impressive efficacy against malaria in laboratory studies. Furthermore, the plant produces cassane furanoditerpenes that possess notable antiviral properties, particularly against the Para3 virus. These findings suggest that this species holds great promise for the development of new therapeutic agents to combat infectious diseases.
Compounds
Guilandina minax serves as a rich natural source for a variety of complex chemical compounds. Recent phytochemical investigations have revealed that this plant contains several specific cassane furanoditerpenes, including caesalmin C, D, and F. In addition to these derivatives, researchers have successfully isolated the compound known as magnicaesalpin from its seeds. The chemical profile is further expanded by the presence of minaxin C, another significant diterpene found within the species. Together, these diverse constituents highlight the plant's significant potential for pharmacological development.
Conditions
Guilandina minax, also identified as Caesalpinia minax, demonstrates significant antineoplastic potential through its bioactive cassane-type diterpenes. Research shows that extracts from this plant effectively treat HepG-2 and MCF-7 cancer cell lines with notable antiproliferative activity. Furthermore, specific compounds derived from the plant exhibit cytotoxicity against A549 cells. The plant's components also demonstrate an ability to treat AGS cells through selective cytotoxic actions. Finally, the chemical constituents of Guilandina minax have been shown to treat HCT-8 cells, displaying moderate cytotoxicity.
Preparations
Guilandina minax is prepared as seeds to facilitate the isolation of novel dinorcassane- and cassane-type diterpenes. These seeds serve as the primary source for identifying bioactive compounds such as norcaesalpinin I and caesalpinin U. Furthermore, the plant is prepared as an ethyl acetate extract to yield various bioactive cassane-type diterpenes known as caesalpins A-H. This extraction process allows for the recovery of specific chemical constituents that exhibit significant antiproliferative and cytotoxic activities. Consequently, both the raw seeds and the resulting ethyl acetate extract are essential for studying the plant's medicinal potential.
Parts used
Guilandina minax, also identified in scientific literature as Caesalpinia minax, serves as a rich source of bioactive secondary metabolites. Research highlights that the seeds of this plant contain a variety of unique cassane-type diterpenes and diterpene alkaloids. These specialized compounds, such as neocaesalpin and caesalminines, have demonstrated significant pharmacological potential. Specifically, the chemical constituents found within the seeds exhibit both antineoplastic and antimalarial activities. Consequently, the seed component of this species remains a focal point for discovering novel therapeutic agents against cancer and malaria.